Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesEndocrinologymedimpact TRUE METRIX recall — Coverage Update | O…
    Ask Trek AI about this page
    CurrentmedimpactPolicy N/A

    True Metrix Blood Glucose Monitoring Systems Recall — Provider Guidance

    Customize your policy alerts

    Sign up for all medimpact policy alerts

    Know when medimpact releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Notice to Kentucky Medicaid providers about a Class I recall and labeling correction for TRUE METRIX family blood glucose monitoring systems; directs providers on patient counseling, temporary replacement supplies, and where to report adverse events.

    Policy Summary
    Payermedimpact
    PolicyTrue Metrix Blood Glucose Monitoring Systems Recall — Provider Guidance
    Policy CodePolicy N/A
    Change TypeLabeling correction / recall notice
    Effective DateMay 1, 2026
    Next Review DateN/A
    Key ActionInform patients of the recall, follow updated E-5 error instructions, and help transition to alternative testing or obtain a temporary replacement meter with 50 strips.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    Class 1FDA recall severity
    114reported injuries
    1reported deaths
    50 stripstemporary replacement kit

    Provider Guidance and Coverage Actions

    Provider actions during recall

    Recommended actions for providers caring for patients using TRUE METRIX devices:

    Notify and counsel patients: Inform patients immediately about the recall and the updated E-5 error code instructions; instruct them to follow the updated guidance and to not stop testing until an alternative testing method is available.

    Supported by Trividia/FDA recall notice and MedImpact provider recommendations.

    Transition to alternative testing: When possible, transition patients to an alternative method for blood glucose testing until corrected meters are available; assist patients in obtaining temporary replacement meters and a box of 50 test strips through Trividia's support channels.

    Trividia has a third‑party distribution program that can send a temporary replacement meter and 50 test strips to patients.

    E-5 error response: If the device displays an E-5 error, have the patient repeat the test with a new strip. If the error persists and the patient has symptoms of hyperglycemia (fatigue, increased urination, excessive thirst, blurry vision) seek medical care immediately. If the patient is asymptomatic and the error persists, advise them to call Trividia support for further assistance.blood glucose >600 mg/dL implied

    Updated labeling clarifies E-5 can indicate >600 mg/dL or a strip error and emphasizes immediate medical attention if symptomatic.

    The manufacturer has not provided a comprehensive NDC list beyond the specific affected NDCs published in the recall notice. The notice therefore lists the TRUE METRIX, TRUE METRIX AIR, TRUE METRIX GO, and TRUE METRIX PRO products that may be impacted and their associated NDCs rather than supplying a separate master exclusion list. No additional exclusions or coverage limitations are stated in the notice.

    Affected Codes and Coding Details

    Affected NDCs (listed by manufacturer)NDC
    11917017389True Metrix Air Glucose meter NDC listed in recall notice
    56151149002True Metrix Air Glucose meter NDC listed in recall notice
    56151149102True Metrix Air Glucose meter NDC listed in recall notice
    56151149403True Metrix Air Glucose meter NDC listed in recall notice
    87701042739True Metrix Air Glucose meter NDC listed in recall notice
    56151149401True Metrix Air Glucose meter NDC listed in recall notice
    08528147401True Metrix Blood Glucose meter NDC listed in recall notice
    21292000605True Metrix Blood Glucose meter NDC listed in recall notice
    56151147002True Metrix Blood Glucose meter NDC listed in recall notice
    87701042625True Metrix Blood Glucose meter NDC listed in recall notice
    1–10 of 12
    1/2

    Operational Steps for Providers

    Prior Authorization

    Prior authorization contact points — no change to prior auth policy

    For prior authorization questions related to Kentucky Medicaid, use the Kentucky MCO or FFS contact points provided; this notice does not change prior authorization policy for diabetic supplies.

    • KY MCO Prior Authorizations: Phone (844) 336-2676 [8:00AM - 7:00PM EST/7 days]; Fax (858) 357-2612; Pharmacy Help Desk: (800) 210-7628 (24/7); Portal: https://kyportal.medimpact.com/.
    • KY FFS Prior Authorizations: Phone (877) 403-6034 [8:00AM - 7:00PM EST/7 days]; Pharmacy Help Desk: (877) 403-6034 (24/7); Portal: https://kyportal.medimpact.com/.
    Step Therapy

    No step therapy required; advise transition to alternatives

    There are no step therapy requirements specified in the notice; providers are instructed to transition patients to alternative blood glucose testing methods when possible until corrected meters are available.

    • Users should continue testing and should not stop using their TRUE METRIX meter until an alternative is available.
    • Transition patients to alternative testing methods if possible until corrected meters are available.
    Documentation Required

    Document and notify patients and facilities of the recall

    Inform patients immediately about the recall and updated E-5 error code instructions, and post the 'URGENT MEDICAL DEVICE CORRECTION' HCP notice in areas where products are stored; provide Trividia contact information for adverse events or questions.

    • Instruct patients to follow the updated E-5 guidance or visit www.trividiahealth.com for Owner's Booklets and resources.
    • For facilities: post the 'URGENT MEDICAL DEVICE CORRECTION' HCP notice where products are stored.
    • Trividia contact for questions or adverse reactions: trividia0126CC@trividiahealth.com or 1-888-835-2723; consumer support 1-800-803-6025 (Mon–Fri, 8 AM–8 PM EST).
    Billing Rule

    Billing and coverage — no explicit denials stated

    The notice does not state any explicit billing or coverage denials; guidance centers on transitioning patients to alternative glucose testing and continuing testing until alternatives are available.

    • No explicit billing or coverage denials are provided in the recall communication.
    • Focus is on patient transition to alternative testing and ensuring ongoing glucose monitoring until replacements are accessible.

    Device Background and Recall Summary

    The TRUE METRIX family of blood glucose meters can display an E-5 error, which may indicate either a test strip error or a very high blood glucose level (typically >600 mg/dL). The manufacturer has updated device labeling to emphasize that users who receive an E-5 error and who are experiencing symptoms of hyperglycemia should seek immediate medical attention. Providers should be aware that incorrect prior instructions could delay urgent care for symptomatic hyperglycemia, increasing risk of dehydration, altered mental status, or worse.

    Key Terms and Device Messages

    inv-09: E-5 error code — device message indicating either a test strip error or a very high blood glucose; updated labeling emphasizes interpretation
    DefinitionE-5 error code: device message indicating either a very high blood glucose event (>600 mg/dL) or a test strip error.
    Updated labeling actionTrividia corrected the E-5 instructions in Owner's Booklets, online labeling, and help guides to emphasize immediate medical attention when symptomatic.
    If symptomaticRepeat test with a new strip; if error persists and patient has symptoms (fatigue, polyuria, polydipsia, blurry vision), seek medical care right away.
    If asymptomaticRetest with a new strip; if error persists, call Trividia support (1-800-803-6025, Mon-Fri 8 AM–8 PM EST) for further assistance.
    Safety rationaleOriginal wording could delay treatment for symptomatic hyperglycemia, risking dehydration, altered mental status, or death; 114 serious injuries and 1 death reported.
    Policy Summary
    Payermedimpact
    PolicyTrue Metrix Blood Glucose Monitoring Systems Recall — Provider Guidance
    Policy CodePolicy N/A
    Change TypeLabeling correction / recall notice
    Effective DateMay 1, 2026
    Next Review DateN/A
    Key ActionInform patients of the recall, follow updated E-5 error instructions, and help transition to alternative testing or obtain a temporary replacement meter with 50 strips.
    SourceLink
    On This Page
    Provider Guidance and Coverage ActionsAffected Codes and Coding DetailsOperational Steps for ProvidersDevice Background and Recall SummaryKey Terms and Device Messages

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.